Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Pulmonary Medicine
Published in: BMC Pulmonary Medicine 1/2021

Open Access 01-12-2021 | Chronic Obstructive Lung Disease | Research

Effect of counselling during pulmonary rehabilitation on self-determined motivation to be physically active for people with chronic obstructive pulmonary disease: a pragmatic RCT

Authors: Anne-Kathrin Rausch Osthoff, Swantje Beyer, David Gisi, Spencer Rezek, Ariane Schwank, André Meichtry, Noriane A. Sievi, Thomas Hess, Markus Wirz

Published in: BMC Pulmonary Medicine | Issue 1/2021

Login to get access

Abstract

Background

Counselling is considered to be a promising approach to increasing physical activity (PA) in people with chronic obstructive pulmonary disease (COPD). The aim of the current study was to investigate whether a PA counselling program for people with COPD, when embedded in a comprehensive outpatient pulmonary rehabilitation (PR) program, increased their daily PA.

Methods

A two-armed, single blind randomized controlled trial was conducted as a component of a 12-week outpatient pulmonary rehabilitation program. The participants randomized into the intervention group received five counselling sessions, based on the principles of motivational interviewing (MI), with a physiotherapist. The participants’ steps per day and other proxies of PA were measured using an accelerometer (SenseWear Pro®) at baseline, at the end of the PR program, and three months later. The group-by-time interaction effect was analyzed.

Results

Of the 43 participants,17 were allocated to the intervention group and 26 to the usual-care control group (mean age 67.9 ± 7.9; 21 (49%) males; mean FEV1 predicted 47.1 ± 18.6). No difference between groups was found for any measure of PA at any point in time.

Conclusions

In this study, counselling, based on MI, when embedded in a comprehensive PR program for people with COPD, showed no short-term or long-term effects on PA behavior. To investigate this potentially effective counselling intervention and to analyze the best method, timing and tailoring of an intervention embedded in a comprehensive outpatient PR program, further adequately powered research is needed.
Trial registration: Clinical Trials.gov NCT02455206 (05/21/2015), Swiss National Trails Portal SNCTP000001426 (05/21/2015).
Literature
1.
Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J, Carone M, Celli B, Engelen M, Fahy B, et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med. 2006;173(12):1390–413.PubMedCrossRef
2.
Garcia-Aymerich J, Farrero E, Felez MA, Izquierdo J, Marrades RM, Anto JM. Estudi del Factors de Risc d’Aguditzacio de la Mi: risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax. 2003;58(2):100–5.PubMedPubMedCentralCrossRef
3.
Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax. 2006;61(9):772–8.PubMedPubMedCentralCrossRef
4.
Pitta F, Troosters T, Probst VS, Spruit MA, Decramer M, Gosselink R. Physical activity and hospitalization for exacerbation of COPD. Chest. 2006;129(3):536–44.PubMedCrossRef
5.
Waschki B, Kirsten A, Holz O, Muller KC, Meyer T, Watz H, Magnussen H. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest. 2011;140(2):331–42.PubMedCrossRef
6.
Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–65.PubMedCrossRef
7.
Donaire-Gonzalez D, Gimeno-Santos E, Balcells E, de Batlle J, Ramon MA, Rodriguez E, Farrero E, Benet M, Guerra S, Sauleda J, et al. Benefits of physical activity on COPD hospitalisation depend on intensity. Eur Respir J. 2015;46(5):1281–9.PubMedCrossRef
8.
Ward TJC, Plumptre CD, Dolmage TE, Jones AV, Trethewey R, Divall P, Singh SJ, Lindley MR, Steiner MC, Evans RA. Change in (V)over dotO(2peak) in response to aerobic exercise training and the relationship with exercise prescription in people with COPD a systematic review and meta-analysis. Chest. 2020;158(1):131–44.PubMedCrossRef
9.
Geidl W, Schlesinger S, Mino E, Miranda L, Pfeifer K. Dose-response relationship between physical activity and mortality in adults with noncommunicable diseases: a systematic review and meta-analysis of prospective observational studies. Int J Behav Nutr Phys Act. 2020;17(1):109.PubMedPubMedCentralCrossRef
10.
Lopez-Campos JL, Soler-Cataluna JJ, Miravitlles M. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2019 report: future challenges. Arch Bronconeumol. 2020;56(2):65–7.PubMedCrossRef
11.
12.
Lima F, Altero G, Franco MC, Pinto R, Freire AP, Gomes P, Camillo CA, Ramos D, Ramos EM. Factors influencing participation and adherence to a pulmonary rehabilitation program in patients with COPD: a qualitative study. Eur Respir J. 2016;48.
13.
Guo SE, Bruce A. Improving understanding of and adherence to pulmonary rehabilitation in patients with COPD: a qualitative inquiry of patient and health professional perspectives. PLoS ONE. 2014;9:10.PubMedCentralCrossRef
14.
Hayton C, Clark A, Olive S, Browne P, Galey P, Knights E, Staunton L, Jones A, Coombes E, Wilson AM. Barriers to pulmonary rehabilitation: characteristics that predict patient attendance and adherence. Respir Med. 2013;107(3):401–7.PubMedCrossRef
15.
Pitta F, Burtin C. Erratum to: The physical activity coach in pulmonary rehabilitation. In: Clini EM, Holland AE, Pitta F, Troosters T, editors. Textbook of pulmonary rehabilitation. Cham: Springer; 2017.
16.
(UK) NGUT: NICE Guideline, No. 115. In: Self-management interventions, education and telehealth monitoring: chronic obstructive pulmonary disease in over 16s: diagnosis and management: evidence review C. edn. London: National Institute for Health and Care Excellence (UK); 2018.
17.
Miller WR, Rollnick S. Motivational interviewing. Preparing people to change. 3rd ed. New London: The Guildford Press; 2013.
18.
Zidarn M, Kolenko A. Effectiveness of motivational interview for smoking cessation in hospital setting. Eur Respir J. 2016;48.
19.
Efraimsson EO, Fossum B, Ehrenberg A, Larsson K, Klang B. Use of motivational interviewing in smoking cessation at nurse-led chronic obstructive pulmonary disease clinics. J Adv Nurs. 2012;68(4):767–82.PubMedCrossRef
20.
Naderloo H, Vafadar Z, Eslaminejad A, Ebadi A. Effects of Motivational Interviewing on treatment adherence among patients with chronic obstructive pulmonary disease: a randomized controlled clinical trial. Tanaffos. 2018;17(4):241–9.PubMedPubMedCentral
21.
de Blok BM, de Greef MH, ten Hacken NH, Sprenger SR, Postema K, Wempe JB. The effects of a lifestyle physical activity counseling program with feedback of a pedometer during pulmonary rehabilitation in patients with COPD: a pilot study. Patient Educ Couns. 2006;61(1):48–55.PubMedCrossRef
22.
Burtin C, Langer D, van Remoortel H, Demeyer H, Gosselink R, Decramer M, Dobbels F, Janssens W, Troosters T. Physical activity counselling during pulmonary rehabilitation in patients with COPD: a randomised controlled trial. PLoS ONE. 2015;10(12):4989.CrossRef
23.
Altenburg WA, ten Hacken NH, Bossenbroek L, Kerstjens HA, de Greef MH, Wempe JB. Short- and long-term effects of a physical activity counselling programme in COPD: a randomized controlled trial. Respir Med. 2015;109(1):112–21.PubMedCrossRef
24.
Cruz J, Brooks D, Marques A. Walk2Bactive: a randomised controlled trial of a physical activity-focused behavioural intervention beyond pulmonary rehabilitation in chronic obstructive pulmonary disease. Chron Respir Dis. 2016;13(1):57–66.PubMedCrossRef
25.
Lahham A, McDonald CF, Holland AE. Exercise training alone or with the addition of activity counseling improves physical activity levels in COPD: a systematic review and meta-analysis of randomized controlled trials. Int J Chron Obstruct Pulmon Dis. 2016;11:3121–36.PubMedPubMedCentralCrossRef
26.
Benzo R, Vickers K, Novotny PJ, Tucker S, Hoult J, Neuenfeldt P, Connett J, Lorig K, McEvoy C. Health coaching and chronic obstructive pulmonary disease rehospitalization a randomized study. Am J Respir Crit Care Med. 2016;194(6):672–80.PubMedPubMedCentralCrossRef
27.
Arbillaga-Etxarri A, Gimeno-Santos E, Barberan-Garcia A, Balcells E, Benet M, Borrell E, Celorrio N, Delgado A, Jane C, Marin A, et al. Long-term efficacy and effectiveness of a behavioural and community-based exercise intervention (Urban Training) to increase physical activity in patients with COPD: a randomised controlled trial. Eur Respir J. 2018;52:4.CrossRef
28.
Benzo RP, Kirsch JL, Hathaway JC, McEvoy CE, Vickers KS. Health coaching in severe COPD after a hospitalization: a qualitative analysis of a large randomized study. Respir Care. 2017;62(11):1403–11.PubMedPubMedCentralCrossRef
29.
Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Health Promot. 1997;12(1):38–48.PubMedCrossRef
30.
Langer D, Demeyer H. Interventions to modify physical activity in patients with COPD: where do we go from here? Eur Respir J. 2016;48(1):14–7.PubMedCrossRef
31.
Rausch-Osthoff AK, Greco N, Schwank A, Beyer S, Gisi D, Scheermesser M, Meichtry A, Sievi N, Hess T, Wirz M. Effect of counselling during pulmonary rehabilitation on self-determined motivation towards physical activity in people with chronic obstructive pulmonary disease-protocol of a mixed methods study. BMC Pulm Med. 2017;17(1):115.PubMedPubMedCentralCrossRef
32.
Spruit MA, Singh SJ, Garvey C, ZuWallack R, Nici L, Rochester C, Hill K, Holland AE, Lareau SC, Man WD, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13-64.PubMedCrossRef
33.
Maltais F, LeBlanc P, Jobin J, Berube C, Bruneau J, Carrier L, Breton MJ, Falardeau G, Belleau R. Intensity of training and physiologic adaptation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1997;155(2):555–61.PubMedCrossRef
34.
Bekkering EC, Hendriks HJM, Paterson WJ. Guidelines for physiotherapeutic management in chronic obstructive pulmonary disease (COPD). Phys Ther Rev. 2000;5:559–74.CrossRef
35.
Puhan MA, Schunemann HJ, Frey M, Scharplatz M, Bachmann LM. How should COPD patients exercise during respiratory rehabilitation? Comparison of exercise modalities and intensities to treat skeletal muscle dysfunction. Thorax. 2005;60(5):367–75.PubMedPubMedCentralCrossRef
36.
Gloeckl R, Marinov B, Pitta F. Practical recommendations for exercise training in patients with COPD. Eur Respir Rev Off J Eur Respir Soc. 2013;22(128):178–86.CrossRef
37.
Moyers TB, Rowell LN, Manuel JK, Ernst D, Houck JM. The Motivational Interviewing treatment integrity code (MITI 4): Rationale, preliminary reliability and validity. J Subst Abuse Treat. 2016;65:36–42.PubMedPubMedCentralCrossRef
38.
39.
Hettema JE, Ernst D, Williams JR, Miller KJ. Parallel processes: using motivational interviewing as an implementation coaching strategy. J Behav Health Serv Res. 2014;41(3):324–36.PubMedCrossRef
40.
Aliverti A, Macklem PT. The major limitation to exercise performance in COPD is inadequate energy supply to the respiratory and locomotor muscles. J Appl Physiol. 2008;105(2):749–51.PubMedCrossRef
41.
Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381–95.PubMedCrossRef
42.
Kim Y, Park I, Kang M. Convergent validity of the international physical activity questionnaire (IPAQ): meta-analysis. Public Health Nutr. 2013;16(3):440–52.PubMedCrossRef
43.
Markland D, Tobin V. A modification to the behavioural regulation in exercise questionnaire to include an assessment of amotivation. J Sport Exerc Psychol. 2004;26(2):191–6.CrossRef
44.
Wilson PM, Rodgers WM, Loitz CC, Scrime G. “It’s who I am…really!” The importance of integrated regulation in exercise contexts. J Biobehav Res. 2006;11:79–104.CrossRef
45.
Prochaska JO, DiClemente CC. Transtheoretical therapy: towards a more integrative model of change. Psychother Theory Res Pract. 1982;19(3):276–88.CrossRef
46.
Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987;42(10):773–8.PubMedPubMedCentralCrossRef
47.
Reda AA, Kotz D, Kocks JW, Wesseling G, van Schayck CP. Reliability and validity of the clinical COPD questionniare and chronic respiratory questionnaire. Respir Med. 2010;104(11):1675–82.PubMedCrossRef
48.
Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3):648–54.PubMedCrossRef
49.
Sievi NA, Franzen D, Kohler M, Clarenbach CF. Physical inactivity and arterial stiffness in COPD. Int J Chron Obstruct Pulmon Dis. 2015;10:1891–7.PubMedPubMedCentral
50.
Watz H, Waschki B, Meyer T, Magnussen H. Physical activity in patients with COPD. Eur Respir J. 2009;33(2):262–72.PubMedCrossRef
51.
Bates D, Machler M, Bolker BM, Walker SC. Fitting linear mixed-effects models using lme4. J Stat Softw. 2015;67(1):1–48.CrossRef
52.
A Language and Environment for Statistical Computing.
53.
Demeyer H, Burtin C, Hornikx M, Camillo CA, Van Remoortel H, Langer D, Janssens W, Troosters T. The minimal important difference in physical activity in patients with COPD. PLoS ONE. 2016;11(4):e0154587.PubMedPubMedCentralCrossRef
54.
Scheermesser M, Reicherzer L, Beyer S, Gisi D, Rezek S, Hess T, Wirz M, Rausch Osthoff AK. The influence of pulmonary rehabilitation and counselling on perceptions of physical activity in individuals with COPD—a qualitative study. Int J Chron Obstruct Pulmon Dis. 2021;16:2337–50.PubMedPubMedCentralCrossRef
55.
O’Halloran PD, Blackstock F, Shields N, Holland A, Iles R, Kingsley M, Bernhardt J, Lannin N, Morris ME, Taylor NF. Motivational interviewing to increase physical activity in people with chronic health conditions: a systematic review and meta-analysis. Clin Rehabil. 2014;28(12):1159–71.PubMedCrossRef
56.
Chapter 6 Intervention Mapping Step 3 Program design. In: Planning health promotion programs. Fourth edn. Edited by Bartholomew Eldredge LK, Markham CM, Ruiter RAC, Fernandez ME, Kok G, Parcel GS. San Francisco, USA: Jossey-Bass; 2016.
57.
Mantoani LC, Rubio N, McKinstry B, MacNee W, Rabinovich RA. Interventions to modify physical activity in patients with COPD: a systematic review. Eur Respir J. 2016;48(1):69–81.PubMedCrossRef
58.
Organisation WH. World Health Organization. Implementation tools: package of essential noncommunicable (PEN) disease interventions for primary health care in low-resource settings. In. Edited by Organization WH. Geneva; 2013.
59.
WHO Guidelines on Physical Activity and Sedentary Behaviour
60.
Cindy Ng LW, Mackney J, Jenkins S, Hill K. Does exercise training change physical activity in people with COPD? A systematic review and meta-analysis. Chron Respir Dis. 2012;9(1):17–26.PubMedCrossRef
61.
Pitta F, Troosters T, Probst VS, Langer D, Decramer M, Gosselink R. Are patients with COPD more active after pulmonary rehabilitation? Chest. 2008;134(2):273–80.PubMedCrossRef
62.
Wempe JB, Wijkstra PJ. The influence of rehabilitation on behaviour modification in COPD. Patient Educ Couns. 2004;52(3):237–41.PubMedCrossRef
63.
Polkey MI, Rabe KF. Chicken or egg: physical activity in COPD revisited. Eur Respir J. 2009;33(2):227–9.PubMedCrossRef
64.
Blondeel A, Demeyer H, Janssens W, Troosters T. The role of physical activity in the context of pulmonary rehabilitation. COPD. 2018;15(6):632–9.PubMedCrossRef
65.
Holland AE, Mahal A, Hill CJ, Lee AL, Burge AT, Moore R, Nicolson C, O’Halloran P, Cox NS, Lahham A, et al. Benefits and costs of home-based pulmonary rehabilitation in chronic obstructive pulmonary disease—a multi-centre randomised controlled equivalence trial. BMC Pulm Med. 2013;13:57.PubMedPubMedCentralCrossRef
66.
Cox NS, Dal Corso S, Hansen H, McDonald CF, Hill CJ, Zanaboni P, Alison JA, O’Halloran P, Macdonald H, Holland AE. Telerehabilitation for chronic respiratory disease. Cochrane Database System Rev. 2021;1:CD013040.
67.
Cox NS, McDonald CF, Alison JA, Mahal A, Wootton R, Hill CJ, Bondarenko J, Macdonald H, O’Halloran P, Zanaboni P, et al. Telerehabilitation versus traditional centre-based pulmonary rehabilitation for people with chronic respiratory disease: protocol for a randomised controlled trial. BMC Pulm Med. 2018;18(1):71.PubMedPubMedCentralCrossRef
68.
Hansen H, Bieler T, Beyer N, Kallemose T, Wilcke JT, Ostergaard LM, Frost Andeassen H, Martinez G, Lavesen M, Frolich A, et al. Supervised pulmonary tele-rehabilitation versus pulmonary rehabilitation in severe COPD: a randomised multicentre trial. Thorax. 2020;75(5):413–21.PubMedCrossRef
69.
Damhus CS, Emme C, Hansen H. Barriers and enablers of COPD telerehabilitation—a frontline staff perspective. Int J Chron Obstruct Pulmon Dis. 2018;13:2473–82.PubMedPubMedCentralCrossRef
70.
Rosenbek Minet L, Hansen LW, Pedersen CD, Titlestad IL, Christensen JK, Kidholm K, Rayce K, Bowes A, Mollegard L. Early telemedicine training and counselling after hospitalization in patients with severe chronic obstructive pulmonary disease: a feasibility study. BMC Med Inform Decis Mak. 2015;15:3.PubMedPubMedCentralCrossRef
71.
Oates GR, Niranjan SJ, Ott C, Scarinci IC, Schumann C, Parekh T, Dransfield MT. Adherence to pulmonary rehabilitation in copd a qualitative exploration of patient perspectives on barriers and facilitators. J Cardiopulm Rehabil Prev. 2019;39(5):344–9.PubMedPubMedCentralCrossRef
72.
Weiterbildung für Gesundheitsfachpersonen.
73.
Rehabilitation P. Das Lehr- und Lernbuch für dsa Reha-Team der D-A-CH Arbeitsgesmeinschaft Pneumologische Rehabilitation. München: Dustri-Veralg Dr.Karl Feistle; 2020.
74.
Van Remoortel H, Raste Y, Louvaris Z, Giavedoni S, Burtin C, Langer D, Wilson F, Rabinovich R, Vogiatzis I, Hopkinson NS, et al. Validity of six activity monitors in chronic obstructive pulmonary disease: a comparison with indirect calorimetry. PLoS ONE. 2012;7(6):e39198.PubMedPubMedCentralCrossRef
75.
Hill K, Dolmage TE, Woon L, Goldstein R, Brooks D. Measurement properties of the sensewear armband in adults with chronic obstructive pulmonary disease. Thorax. 2010;65(6):486–91.PubMedCrossRef
Metadata
Title
Effect of counselling during pulmonary rehabilitation on self-determined motivation to be physically active for people with chronic obstructive pulmonary disease: a pragmatic RCT
Authors
Anne-Kathrin Rausch Osthoff
Swantje Beyer
David Gisi
Spencer Rezek
Ariane Schwank
André Meichtry
Noriane A. Sievi
Thomas Hess
Markus Wirz
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2021
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-021-01685-2

Other articles of this Issue 1/2021

BMC Pulmonary Medicine 1/2021 Go to the issue

Research article

Preliminary development of a questionnaire to measure the extra-pulmonary symptoms of severe asthma

Research

Incidence, aetiology and clinical features of eosinophilic pleural effusion: a retrospective study

Research

Outcomes of adjunctive surgery for nontuberculous mycobacterial pulmonary disease

Case report

Patent foramen ovale revealed by COVID-19 pneumonia

Research

Long non-coding RNA GATA6-AS1 upregulates GATA6 to regulate the biological behaviors of lung adenocarcinoma cells

Research

Baseline plasma KL-6 level predicts adverse outcomes in patients with idiopathic pulmonary fibrosis receiving nintedanib: a retrospective real-world cohort study
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits